The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
NCT00332397
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1007
Enrollment
OTHER
Sponsor class
Conditions
Coronary Disease
Interventions
DEVICE:
Rapamycin-eluting Stent
DEVICE:
Zotarolimus-eluting Stent
DEVICE:
Rapamycin-eluting Stent
Sponsor
Deutsches Herzzentrum Muenchen